Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Defining The Biological Basis Of Radiomic Phenotypes In Lung Cancer
P. Grossmann, O. Stringfield, N. El-Hachem, M. Bui, E. Rios Velazquez, Chintan Parmar, R. Leijenaar, B. Haibe-Kains, P. Lambin, R. Gillies, H. Aerts
Published 2017 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Medical imaging can visualize characteristics of human cancer noninvasively. Radiomics is an emerging field that translates these medical images into quantitative data to enable phenotypic profiling of tumors. While radiomics has been associated with several clinical endpoints, the complex relationships of radiomics, clinical factors, and tumor biology are largely unknown. To this end, we analyzed two independent cohorts of respectively 262 North American and 89 European patients with lung cancer, and consistently identified previously undescribed associations between radiomic imaging features, molecular pathways, and clinical factors. In particular, we found a relationship between imaging features, immune response, inflammation, and survival, which was further validated by immunohistochemical staining. Moreover, a number of imaging features showed predictive value for specific pathways; for example, intra-tumor heterogeneity features predicted activity of RNA polymerase transcription (AUC = 0.62, p=0.03) and intensity dispersion was predictive of the autodegration pathway of a ubiquitin ligase (AUC = 0.69, p<10-4). Finally, we observed that prognostic biomarkers performed highest when combining radiomic, genetic, and clinical information (CI = 0.73, p<10-9) indicating complementary value of these data. In conclusion, we demonstrate that radiomic approaches permit noninvasive assessment of both molecular and clinical characteristics of tumors, and therefore have the potential to advance clinical decision-making by systematically analyzing standard-of-care medical images. DOI: http://dx.doi.org/10.7554/eLife.23421.001
This paper references
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
O. Gevaert (2014)
Behind the numbers: Decoding molecular phenotypes with radiogenomics--guiding principles and technical considerations.
M. Kuo (2014)
The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review.
H. Aerts (2016)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
A. Sottoriva (2013)
Interactions between the tumor suppressor p53 and immune responses
D. Menéndez (2013)
Combining probability from independent tests: the weighted Z‐method is superior to Fisher's approach
M. Whitlock (2005)
Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction
J. Hou (2010)
Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma
O. Grove (2015)
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
M. Diehn (2008)
The 7th lung cancer TNM classification and staging system: Review of the changes and implications.
S. Mirsadraee (2012)
Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer.
Yanqi Huang (2016)
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
H. Aerts (2014)
affy - analysis of Affymetrix GeneChip data at the probe level
L. Gautier (2004)
Evaluating the yield of medical tests.
F. Harrell (1982)
Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer.
D. Fried (2014)
Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
Sarah A. Mattonen (2016)
Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?
G. Cook (2013)
Somatic mutations associated with MRI-derived volumetric features in glioblastoma
D. Gutman (2015)
Controlling the false discovery rate: a practical and powerful approach to multiple testing
Y. Benjamini (1995)
Non-small cell lung cancer: histopathologic correlates for texture parameters at CT.
B. Ganeshan (2013)
Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.
O. Gevaert (2012)
survcomp: an R/Bioconductor package for performance assessment and comparison of survival models
Markus S. Schröder (2011)
Radiomics: the process and the challenges.
Virendra Kumar (2012)
Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging.
Aaron M Rutman (2009)
Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach
Hyun Jung Yoon (2015)
Tumor Suppressors and Cell-Cycle Proteins in Lung Cancer
A. Baldi (2011)
Tumor Heterogeneity and Permeability as Measured on the CT Component of PET/CT Predict Survival in Patients with Non–Small Cell Lung Cancer
T. Win (2013)
Radiomics: Images Are More than Pictures, They Are Data
R. Gillies (2016)
Reproducibility of radiomics for deciphering tumor phenotype with imaging
B. Zhao (2016)
Iterative signature algorithm for the analysis of large-scale gene expression data.
S. Bergmann (2003)
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
M. Gerlinger (2012)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Hänzelmann (2012)
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma.
T. Coroller (2015)
mRMRe: an R package for parallelized mRMR ensemble feature selection
Nicolas De Jay (2013)
Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer
Chintan Parmar (2015)
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
H. Li (2016)
Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability
R. Leijenaar (2013)
A Fourth Edition
G. Horn (1945)
Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma
P. Grossmann (2016)
A Four-Gene Signature from NCI-60 Cell Line for Survival Prediction in Non–Small Cell Lung Cancer
Yi-Chiung Hsu (2009)
Targeting hypoxia in the treatment of small cell lung cancer.
J.L. Bryant (2014)
The use of the area under the ROC curve in the evaluation of machine learning algorithms
A. Bradley (1997)
The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation.
J. Wolchok (2008)
The COP1 E3-ligase interacts with FIP200, a key regulator of mammalian autophagy
S. Kobayashi (2012)
Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.
M. Pencina (2004)
Constitutive Photomorphogensis Protein1 (COP1) mediated p53 pathway and its oncogenic role
M. G. Rabbani (2014)
An introduction to ROC analysis
T. Fawcett (2006)
Decoding global gene expression programs in liver cancer by noninvasive imaging
E. Segal (2007)
Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma
E. Choi (2016)
database ( MSigDB ) 3 . 0
Y Liu (2016)
Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
Yanqi Huang (2016)
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
J. O'Connor (2014)
Imaging biomarker roadmap for cancer studies
J. O’Connor (2017)
Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage
B. Ganeshan (2010)
Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients.
M. Nicolas-Jilwan (2015)
Defining a Radiomic Response Phenotype: A Pilot Study using targeted therapy in NSCLC
H. Aerts (2016)
Radiomics: extracting more information from medical images using advanced feature analysis.
P. Lambin (2012)
Hypoxia-activated prodrugs in cancer therapy: progress to the clinic.
W. Denny (2010)
Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2'-deoxycytidine.
Bao-Zhu Yuan (2004)
Immune Checkpoint Blockade in Cancer Therapy.
M. Postow (2015)
p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.
S. Ahrendt (2003)
A Liberzon (2011)
Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy?
Y. Chong (2014)
CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
S. Rizzo (2015)
Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival
B. Ganeshan (2011)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data.
R. Irizarry (2003)
The blockade of immune checkpoints in cancer immunotherapy
D. Pardoll (2012)
Molecular signatures database (MSigDB) 3.0
A. Liberzon (2011)
The biology underlying molecular imaging in oncology: from genome to anatome and back again.
R. Gillies (2010)
Modular analysis of gene expression data with R
Gábor Csárdi (2010)
Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer
Chintan Parmar (2015)
Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.
Y. Liu (2016)
Cancer heterogeneity: implications for targeted therapeutics
R. Fisher (2013)
R: A language and environment for statistical computing.
R. Team (2014)
Translational research in oncology—10 years of progress and future prospects
J. Doroshow (2014)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Aravind Subramanian (2005)
A five-gene signature and clinical outcome in non-small-cell lung cancer.
H. Chen (2007)
Reproducibility and Prognosis of Quantitative Features Extracted from CT Images.
Y. Balagurunathan (2014)
Fourth Edition. Pattern Recognition
S Theodoridis (2008)
Reactome - A Knowledgebase of Biological Pathways
E. Schmidt (2005)
Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab
P. Grossmann (2017)
This paper is referenced by
Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer
L. Wang (2018)
A deep-learning-based prognostic nomogram integrating microscopic digital pathology and macroscopic magnetic resonance images in nasopharyngeal carcinoma: a multi-cohort study
F. Zhang (2020)
Radiomics for Predicting CyberKnife response in acoustic neuroma: a pilot study
N. C. D'Amico (2018)
Identification of optimal mother wavelets in survival prediction of lung cancer patients using wavelet decomposition‐based radiomic features
Mazen Soufi (2018)
Combining radiomics and mathematical modeling to elucidate mechanisms of resistance to immune checkpoint blockade in non-small cell lung cancer
Daryoush Saeed-Vafa (2017)
Predicting Local Failure after Stereotactic Radiation Therapy in Brain Metastasis using Quantitative CT and Machine Learning*
M. Jaberipour (2020)
Circulating biomarkers of systemic sclerosis – interstitial lung disease
A. Hoffmann-Vold (2020)
Adaptive radiotherapy for head and neck cancers: Fact or fallacy to improve therapeutic ratio?
Y. Q. Li (2018)
The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective.
Robert H Press (2018)
Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images
P. Tian (2021)
Radiomics in cervical cancer: Current applications and future potential.
Y. Ai (2020)
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer
Federico Cucchiara (2020)
Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach
B. Chen (2020)
Emergence of Radiomics: Novel Methodology Identifying Imaging Biomarkers of Disease in Diagnosis, Response, and Progression
E. Florez (2019)
Radiomic features of pretreatment MRI could identify T stage in patients with rectal cancer: Preliminary findings
Y. Sun (2018)
A novel imaging biomarker for survival prediction in EGFR-mutated NSCLC patients treated with TKI
A. Collin (2019)
Radiomics and deep learning in lung cancer
M. Avanzo (2020)
A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer.
Juheon Lee (2018)
Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)–Positive Breast Cancer
Nathaniel Braman (2019)
Adaptive statistical iterative reconstruction (ASIR) affects CT radiomics quantification in primary colorectal cancer
D. Prezzi (2019)
Defining the biological and clinical basis of radiomics: towards clinical imaging biomarkers
P. Grossmann (2018)
Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy.
Hongming Li (2018)
Convolutional Neural Networks for the Automated Segmentation and Recurrence Risk Prediction of Surgically Resected Lung Tumors
Marguerite B. Basta (2020)
Heterogeneity analysis of 18F-FDG PET imaging in oncology: clinical indications and perspectives
P. Lovinfosse (2018)
Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS
Wei-quan Luo (2019)
Vulnerabilities of radiomic signature development: The need for safeguards.
Mattea L Welch (2019)
Locoregional Radiogenomic Models Capture Gene Expression Heterogeneity in Glioblastoma
A. Depeursinge (2018)
Comparison of radiomics tools for image analyses and clinical prediction in nasopharyngeal carcinoma
Zhong-Guo Liang (2019)
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics
M. Sollini (2019)
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer
R. Sicilia (2018)
Reviewing the Role of Artificial Intelligence in Cancer
Shankargouda Patil (2020)
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition
L. Basler (2020)See more